Department of Medical Oncology for Breast Cancer
Peking University Cancer Hospital, Beijing
乳腺肿瘤内科 · Medical Oncology
This department specializes in the diagnosis and treatment of advanced breast cancer. The clinical team focuses on comprehensive care, including chemotherapy, endocrine therapy, and targeted therapy. Treatment plans emphasize individualized approaches based on standardized protocols. The department has extensive experience in managing recurrent and metastatic breast cancer. It served as one of the authors for the medical oncology section of the Chinese version of the NCCN Breast Cancer Treatment Guidelines. The team leads and participates in multiple domestic and international clinical trials.
What the department treats
- Treatment of advanced breast cancer
- Management of recurrent and metastatic breast cancer
- Chemotherapy
- Endocrine therapy
- Targeted therapy
- Participation in clinical trials
Key facts
- The department has 33 open beds.
- The medical staff includes 3 chief physicians, 1 associate chief physician, 5 attending physicians, and 2 resident physicians.
- The department has published over 100 articles, including more than 30 SCI-indexed papers.
As described by the hospital.
Team
18 doctors listed, including 2 chief physicians. Its chief physicians have 15 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Dr. Bin Shao 邵彬 · Associate Professor | Diagnosis and medical treatment of breast cancer, including chemotherapy, endocrine therapy, targeted therapy, and immunotherapy. Focuses on recurrent and metastatic cases involving the liver, bone, lung, brain, chest wall, pleural effusion, and ascites, as well as triple-negative, HER2-positive, drug-resistant, and refractory breast cancer. | 8 |
| Dr. Hanfang Jiang 姜晗昉 | Systemic chemotherapy, targeted therapy, endocrine therapy, and NGS-guided precision treatment for early-stage and metastatic breast cancer, including hormone receptor-positive, triple-negative, and HER2-positive subtypes. | 7 |
Associate chief physicians
- Dr. Ran Ran冉然
- Dr. Xu Liang梁旭
- Dr. Ruyan Zhang张如艳
- Dr. Jiayang Zhang张嘉扬
- Dr. Ying Yan严颖
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion